Atlas Trials

Efficacy of Botulinum Toxin for the Treatment of Dystonia Associated With Parkinson's Disease and Atypical Parkinsonism

Clinical trial NCT04948684 · COMPLETED

Trial details

NCT number
NCT04948684
Sponsor
Hospital Avicenne
Status
COMPLETED
Study type
OBSERVATIONAL
Parkinson DiseaseAtypical ParkinsonismDystonia
Start date
2017-09-01
Primary completion
2021-02-11
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.